Holtz Daniel, Vasudeva Rhythm, Zorn Tyler, Shah Zubair, Dalia Tarun
Internal Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA.
Cardiology, The University of Kansas Medical Center, Kansas City, Kansas, USA.
BMJ Case Rep. 2025 Mar 28;18(3):e264624. doi: 10.1136/bcr-2024-264624.
Aortic root thrombosis (ART) is a rare but serious complication following the placement of continuous-flow left ventricular assist devices (CF-LVAD). We present the case of a patient with idiopathic non-ischaemic cardiomyopathy who developed a non-ST elevation myocardial infarction (NSTEMI) secondary to ART after CF-LVAD placement. The patient was treated conservatively with antiplatelet therapy and increased international normalized ratio (INR) goal with resolution of thrombus on repeat imaging. ART may be an under-recognised complication in patients with CF-LVAD. Stasis of blood at the aortic root in patients with CF-LVAD may contribute to the development of ART. Management of these patients presenting with myocardial infarction should be individualised by using a multidisciplinary team approach. Our case report suggests conservative management of NSTEMI secondary to ART in patients with CF-LVAD with antiplatelet therapy and an increased INR goal as a reasonable treatment approach.
主动脉根部血栓形成(ART)是连续流左心室辅助装置(CF-LVAD)植入后一种罕见但严重的并发症。我们报告了一例特发性非缺血性心肌病患者,在CF-LVAD植入后因ART继发非ST段抬高型心肌梗死(NSTEMI)。该患者接受了抗血小板治疗及提高国际标准化比值(INR)目标值的保守治疗,复查影像显示血栓溶解。ART在CF-LVAD患者中可能是一种未被充分认识的并发症。CF-LVAD患者主动脉根部血液淤滞可能促使ART的发生。对于这些出现心肌梗死的患者,应采用多学科团队方法进行个体化管理。我们的病例报告表明,对于CF-LVAD患者继发于ART的NSTEMI,采用抗血小板治疗及提高INR目标值的保守治疗是一种合理的治疗方法。